Supporting and building Canada’s stem cell and regenerative medicine research sector has been the raison d’être of the Stem Cell Network (SCN) since its inception in 2001. Its work has been supported by the Government of Canada from the beginning.
In just over 17 years, SCN has forged a national community that has transformed stem cell research in Canada, brought research to the point where regenerative medicine is changing clinical practice, and established an outstanding international reputation. SCN has pushed the boundaries of what was a basic research area towards translational outcomes for the clinic and marketplace. SCN has invested $100M in innovative translational research, training and outreach. This strategic funding has benefitted approximately 170 world-class research groups and 2,500 trainees from across Canada. SCN has also catalyzed 18 clinical trials and 17 startup biotechnology companies. Its investigators have leveraged upwards of $100M in partner contributions while SCN has incubated several international and Canadian research networks and organizations.